113 results
Page 3 of 6
S-3
w7ger1 jt
4 Feb 22
Shelf registration
4:36pm
8-K
EX-99.1
y4j5etm1 bh2
10 Nov 21
InMed Pharmaceuticals Reports First Quarter Fiscal 2022 Financial Results and Provides Business Update
1:08pm
DEF 14A
68ws2s7gsrp52dczaul4
28 Oct 21
Definitive proxy
3:07pm
DEFA14A
0ck 1694gnsp7hv
28 Oct 21
Additional proxy soliciting materials
2:54pm
8-K
EX-2.1
o5e72c
13 Oct 21
InMed Pharmaceuticals Completes Acquisition of BayMedica Creating a Market Leader in the Manufacturing of Rare Cannabinoids
5:00pm
8-K
EX-99.1
jn40ibe1mb
30 Sep 21
Regulation FD Disclosure
1:30pm
8-K
EX-99.1
7e8una2nxlfgf97p71n
24 Sep 21
InMed Pharmaceuticals Reports Full Year Fiscal 2021 Financial Results and Provides Business Update
4:07pm
10-K
y4nffh0f
24 Sep 21
Annual report
7:31am
10-K
EX-2.1
r342e 90ni
24 Sep 21
Annual report
7:31am
424B3
wh1e8m ovid
22 Jul 21
Prospectus supplement
10:27am
8-K
EX-10.1
6cp6lzo3lce6ky4
30 Jun 21
InMed Pharmaceuticals Announces $12 Million Private Placement
12:00am